Related Experiment Video
Updated: May 8, 2026

07:44
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
The autosyringe backpack for children with cancer
1Pediactric Division, University of Texas Medical Branch, Galveston, TX, 77550-2777.
Occupational Therapy in Health Care
|August 16, 2013
Summary
This summary describes a backpack device for administering chemotherapy to pediatric oncology patients. The autosyringe backpack allows children greater mobility, supporting their physical, psychosocial, and play development during hospitalization.
Area of Science:
- Pediatric Oncology
- Occupational Therapy
- Medical Device Design
Background:
- Hospitalized pediatric oncology patients often face limitations in mobility and development during chemotherapy.
- Current treatment methods can restrict a child's ability to engage in essential developmental activities.
- There is a need for innovative solutions to improve the quality of life for these young patients.
Purpose of the Study:
- To introduce and describe an autosyringe backpack designed for chemotherapy administration in pediatric oncology.
- To highlight the benefits of increased mobility for hospitalized children undergoing cancer treatment.
- To provide construction details for the described medical device.
Main Methods:
- A Certified Occupational Therapy Assistant developed and utilized an autosyringe backpack.
- The device was employed during chemotherapy administration for pediatric oncology patients.
- Construction information for the autosyringe backpack was documented.
Main Results:
- The autosyringe backpack significantly enhanced patient mobility during chemotherapy.
- The device facilitated physical, psychosocial, and play development in hospitalized children.
- The design allows for greater independence and engagement in age-appropriate activities.
Conclusions:
- The autosyringe backpack is a valuable tool for improving the hospital experience of pediatric oncology patients.
- Increased mobility supported by the device positively impacts developmental outcomes.
- This innovation offers a practical solution for integrating treatment with developmental needs.
More Related Videos
Related Concept Videos
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

